Spotlight on the role of COP1 in tumorigenesis

Nature Reviews Cancer

Volumn 12, Issue 7, 2012, Pages 455-464

  Marine, Jean Christophe ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACTIVATING TRANSCRIPTION FACTOR 4; BETA CATENIN; CALVASCULIN; CRE RECOMBINASE; F BOX PROTEIN; NOTCH1 RECEPTOR; PROTEIN C JUN; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PEA3; UBIQUITIN PROTEIN LIGASE COP1;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANGIOGENESIS; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 1Q; DNA REPAIR; DOWN REGULATION; ENZYME ACTIVITY; EXON; FATTY ACID SYNTHESIS; GENE LOCUS; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; IN VIVO STUDY; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; NONHUMAN; OVARY ADENOCARCINOMA; PHENOTYPE; PLANT DEVELOPMENT; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UBIQUITINATION; UPREGULATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84862763474     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3271     Document Type: Review

References (96)

1. Wang, H., Kang, D., Deng, X. W. & Wei, N. Evidence for functional conservation of a mammalian homologue of the light-responsive plant protein COP1. Curr. Biol. 9, 711-714 (1999).
2. Deng, X. W., Caspar, T. & Quail, P. H. cop1: a regulatory locus involved in light-controlled development and gene expression in Arabidopsis. Genes Dev. 5, 1172-1182 (1991). (Pubitemid 21906028)
3. Scheffner, M., Nuber, U. & Huibregtse, J. M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83 (1995).
4. Chau, V. et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576-1583 (1989). (Pubitemid 19090506)
5. Thrower, J. S., Hoffman, L., Rechsteiner, M. & Pickart, C. M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102 (2000). (Pubitemid 30009229)
6. Hicke, L., Schubert, H. L. & Hill, C. P. Ubiquitin-binding domains. Nature Rev. Mol. Cell Biol. 6, 610-621 (2005). (Pubitemid 41081265)
7. Eddins, M. J., Carlile, C. M., Gomez, K. M., Pickart, C. M. & Wolberger, C. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nature Struct. Mol. Biol. 13, 915-920 (2006). (Pubitemid 44527374)
8. Rodrigo-Brenni, M. C., Foster, S. A. & Morgan, D. O. Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin. Mol. Cell 39, 548-559 (2010).
9. Wickliffe, K. E., Lorenz, S., Wemmer, D. E., Kuriyan, J. & Rape, M. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 144, 769-781(2011).
10. Zheng, N., Wang, P., Jeffrey, P. D. & Pavletich, N. P. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539 (2000).
11. Hoeller, D. & Dikic, I. Targeting the ubiquitin system in cancer therapy. Nature 458, 438-444 (2009).
12. Nakayama, K. I. & Nakayama, K. Ubiquitin ligases: cell-cycle control and cancer. Nature Rev. Cancer 6, 369-381 (2006).
13. Lipkowitz, S. & Weissman, A. M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nature Rev. Cancer 11, 629-643 (2011).
14. Welcker, M. & Clurman, B. E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nature Rev. Cancer 8, 83-93 (2008). (Pubitemid 351161321)
15. Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nature Rev. Cancer 8, 438-449 (2008). (Pubitemid 351744963)
16. Savio, M. G. et al. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene 27, 2401-2411 (2008). (Pubitemid 351521098)
17. Wertz, I. E. et al. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303, 1371-1374 (2004). (Pubitemid 38269430)
18. Dornan, D. et al. COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas. Cancer Res. 64, 7226-7230 (2004). (Pubitemid 39372056)
19. Lee, Y. H. et al. Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. Cancer Res. 70, 8264-8269 (2010).
20. Su, C. H. et al. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res. 71, 884-894 (2011).
21. Migliorini, D. et al. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. J. Clin. Invest. 121, 1329-1343 (2011).
22. Vitari, A. C. et al. COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature 474, 403-406 (2011).
23. Baxter, L. L., Hou, L., Loftus, S. K. & Pavan, W. J. Spotlight on spotted mice: a review of white spotting mouse mutants and associated human pigmentation disorders. Pigment Cell Res. 17, 215-224 (2004). (Pubitemid 38724551)
24. Wei, W. & Kaelin, W. G., Jr. Good COP1 or bad COP1? In vivo veritas. J. Clin. Invest. 121, 1263-1265 (2011).
25. Dornan, D. et al. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science 313, 1122-1126 (2006). (Pubitemid 44300238)
26. Su, C. H. et al. Nuclear export regulation of COP1 by 14-3-3sigma in response to DNA damage. Mol. Cancer 9, 243 (2010).
27. Yi, C., Wang, H., Wei, N. & Deng, X. W. An initial biochemical and cell biological characterization of the mammalian homologue of a central plant developmental switch, COP1. BMC Cell Biol. 3, 30 (2002).
28. Fu, H., Reis, N., Lee, Y., Glickman, M. H. & Vierstra, R. D. Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J. 20, 7096-7107 (2001). (Pubitemid 34062301)
29. Wei, N. & Deng, X. W. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet. 15, 98-103 (1999).
30. Kato, J. Y. & Yoneda-Kato, N. Mammalian COP9 signalosome. Genes Cells 14, 1209-1225 (2009).
31. Yoneda-Kato, N., Tomoda, K., Umehara, M., Arata, Y. & Kato, J. Y. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 24, 1739-1749 (2005). (Pubitemid 40704984)
32. Choi, H. H. et al. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3sigma. Oncogene 30, 4791-4801 (2011).
33. Richardson, K. S. & Zundel, W. The emerging role of the COP9 signalosome in cancer. Mol. Cancer Res. 3, 645-653 (2005). (Pubitemid 43042994)
34. Lee, M. H., Zhao, R., Phan, L. & Yeung, S. C. Roles of COP9 signalosome in cancer. Cell Cycle 10, 3057-3066 (2011).
35. Adler, A. S. et al. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression. Cancer Res. 68, 506-515 (2008). (Pubitemid 351380078)
36. Mori, M., Yoneda-Kato, N., Yoshida, A. & Kato, J. Y. Stable form of JAB1 enhances proliferation and maintenance of hematopoietic progenitors. J. Biol. Chem. 283, 29011-29021 (2008).
37. Zhao, R. et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J. Clin. Invest. 121, 851-865 (2011).
38. Bianchi, E. et al. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J. Biol. Chem. 278, 19682-19690 (2003). (Pubitemid 36799153)
39. Dornan, D. et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92 (2004). (Pubitemid 38620556)
40. Derijard, B. et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037 (1994). (Pubitemid 24106383)
41. Kyriakis, J. M. et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160 (1994). (Pubitemid 24153440)
42. Arias, J. et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229 (1994). (Pubitemid 24236780)
43. Bannister, A. J., Oehler, T., Wilhelm, D., Angel, P. & Kouzarides, T. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11, 2509-2514 (1995). (Pubitemid 26023818)
44. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486 (1995).
45. Zhong, S. P., Ma, W. Y., Quealy, J. A., Zhang, Y. & Dong, Z. Organ-specific distribution of AP-1 in AP-1 luciferase transgenic mice during the maturation process. Am. J. Physiol. Regul. Integr Comp. Physiol. 280, R376-R381 (2001).
46. Huang, C. et al. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J. Biol. Chem. 272, 26325-26331 (1997). (Pubitemid 27458846)
47. Nateri, A. S., Riera-Sans, L., Da Costa, C. & Behrens, A. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303, 1374-1378 (2004). (Pubitemid 38269431)
48. Wei, W., Jin, J., Schlisio, S., Harper, J. W. & Kaelin, W. G., Jr. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8, 25-33 (2005). (Pubitemid 40991812)
49. Gao, M. et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306, 271-275 (2004). (Pubitemid 39336871)
50. Fang, D. & Kerppola, T. K. Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. Proc. Natl Acad. Sci. USA 101, 14782-14787 (2004). (Pubitemid 39410752)
51. Yi, C. et al. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res. 65, 5835-5840 (2005). (Pubitemid 40911188)
52. Fuchs, S. Y., Dolan, L., Davis, R. J. & Ronai, Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13, 1531-1535 (1996). (Pubitemid 26354201)
53. Musti, A. M., Treier, M. & Bohmann, D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275, 400-402 (1997). (Pubitemid 27051620)
54. Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 (2000).
55. Edwards, J., Krishna, N. S., Mukherjee, R. & Bartlett, J. M. The role of c-Jun and c-Fos expression in androgen-independent prostate cancer. J. Pathol. 204, 153-158 (2004). (Pubitemid 39335288)
56. Chen, S. Y. et al. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene 25, 7212-7223 (2006).
57. Ouyang, X. et al. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res. 68, 2132-2144 (2008). (Pubitemid 351521785)
58. Barcellos-Hoff, M. H., Park, C. & Wright, E. G. Radiation and the microenvironment-tumorigenesis and therapy. Nature Rev. Cancer 5, 867-875 (2005).
59. Chi, P. et al. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467, 849-853 (2010).
60. Jane-Valbuena, J. et al. An oncogenic role for ETV1 in melanoma. Cancer Res. 70, 2075-2084 (2010).
61. Kumar-Sinha, C., Tomlins, S. A. & Chinnaiyan, A. M. Recurrent gene fusions in prostate cancer. Nature Rev. Cancer 8, 497-511 (2008).
62. Baert, J. L. et al. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity. Oncogene 29, 1810-1820 (2010).
63. Tomlins, S. A. et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595-599 (2007). (Pubitemid 47206938)
64. Schreiber, M. et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607-619 (1999). (Pubitemid 29131884)
65. Migliorini, D. et al. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell Biol. 22, 5527-5538 (2002). (Pubitemid 34755762)
66. Francoz, S. et al. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc. Natl Acad. Sci. USA 103, 3232-3237 (2006). (Pubitemid 43346453)
67. Marine, J. C. et al. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 13, 927-934 (2006).
68. Fu, X. et al. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage. Proc. Natl Acad. Sci. USA 107, 4579-4584 (2010).
69. Amson, R. et al. Reciprocal repression between P53 and TCTP. Nature Med. 18, 91-99 (2011).
70. Mendrysa, S. M. et al. mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Mol. Cell Biol. 23, 462-472 (2003).
71. Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004). (Pubitemid 38174664)
72. Horn, H. F. & Vousden, K. H. Coping with stress: multiple ways to activate p53. Oncogene 26, 1306-1316 (2007). (Pubitemid 46328472)
73. Li, D. Q. et al. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc. Natl Acad. Sci. USA 106, 17493-17498 (2009).
74. Liu, Y. et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273 (2008).
75. Koo, S. H. et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111 (2005).
76. Kato, S., Ding, J., Pisck, E., Jhala, U. S. & Du, K. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J. Biol. Chem. 283, 35464-35473 (2008).
77. Zhang, Y., Gan, B., Liu, D. & Paik, J. H. FoxO family members in cancer. Cancer Biol. Ther. 12, 253-259 (2011).
78. Sykes, S. M. et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146, 697-708 (2011).
79. Qi, L. et al. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 312, 1763-1766 (2006). (Pubitemid 43962887)
80. Beckers, A. et al. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res. 67, 8180-8187 (2007). (Pubitemid 47395154)
81. Weinstein, I. B. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science 297, 63-64 (2002). (Pubitemid 34743088)
82. Sullivan, J. A., Shirasu, K. & Deng, X.W. The diverse roles of ubiquitin and the 26S proteasome in the life of plants. Nature Rev. Genet. 4, 948-958 (2003). (Pubitemid 37474642)
83. Osterlund, M. T., Hardtke, C. S., Wei, N. & Deng, X. W. Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature 405, 462-466 (2000). (Pubitemid 30367423)
84. Saijo, Y. et al. The COP1-SPA1 interaction defines a critical step in phytochrome A-mediated regulation of HY5 activity. Genes Dev. 17, 2642-2647 (2003). (Pubitemid 37363069)
85. Yi, C. & Deng, X. W. COP1-from plant photomorphogenesis to mammalian tumorigenesis. Trends Cell Biol. 15, 618-625 (2005). (Pubitemid 41619426)
86. Wang, X. et al. Regulation of COP1 nuclear localization by the COP9 signalosome via direct interaction with CSN1. Plant J. 58, 655-667 (2009).
87. Schwechheimer, C. The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development. Biochim. Biophys. Acta 1695, 45-54 (2004). (Pubitemid 39574967)
88. Schwechheimer, C. & Isono, E. The COP9 signalosome and its role in plant development. Eur. J. Cell Biol. 89, 157-162 (2010).
89. Saha, A. & Deshaies, R. J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 32, 21-31 (2008).
90. Dohmann, E. M. et al. The Arabidopsis COP9 signalosome is essential for G2 phase progression and genomic stability. Development 135, 2013-2022 (2008). (Pubitemid 351943365)
91. Hannss, R. & Dubiel, W. COP9 signalosome function in the DDR. FEBS Lett. 585, 2845-2852 (2011).
92. Suzuki, G., Yanagawa, Y., Kwok, S. F., Matsui, M. & Deng, X. W. Arabidopsis COP10 is a ubiquitin-conjugating enzyme variant that acts together with COP1 and the COP9 signalosome in repressing photomorphogenesis. Genes Dev. 16, 554-559 (2002). (Pubitemid 34212488)
93. Yanagawa, Y. et al. Arabidopsis COP10 forms a complex with DDB1 and DET1 in vivo and enhances the activity of ubiquitin conjugating enzymes. Genes Dev. 18, 2172-2181 (2004). (Pubitemid 39166633)
94. Jackson, S. & Xiong, Y. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem. Sci. 34, 562-570 (2009).
95. Seo, H. S. et al. LAF1 ubiquitination by COP1 controls photomorphogenesis and is stimulated by SPA1. Nature 423, 995-999 (2003).
96. Chang, L. et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124, 601-613 (2006). (Pubitemid 43199444)